AT Alaunos Therapeutics, Inc. Stock: price and management transactions · United States · SEC (Form 4)Follow the Alaunos Therapeutics, Inc. stock price and the full management transaction log of the company, a listed issuer based in United States. Shares trade on the US market, under the oversight of SEC (Form 4). Operating in the Health Care sector, Alaunos Therapeutics, Inc. has published 37 insider filings. Market capitalisation: €4.9m. The latest transaction was filed on 11 August 2026 (Attribution). Among the most active insiders: Postma Robert W. The full history is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 11 August 2026
All Executives37 Thresholds0 Prospectus0 Other0
Declarations 37 total
◆ CEO · Executives · 6 Aug 2026
4,363 shares @ US$2.01 Common Stock SEC:0001193125-26-344682:0
◆ Director · Executives · 23 Jul 2026
8,789 shares @ US$1.92 0.35% mcap 1.7% of flow Common Stock SEC:0001193125-26-318100:0
◆ Director · Executives · 23 Jul 2026
8,463 shares @ US$1.92 0.34% mcap 2.4% of flow Common Stock SEC:0001193125-26-318103:0
◆ CEO · Executives · 23 Jul 2026
4,568 shares @ US$1.92 0.18% mcap 50.4% of flow Common Stock SEC:0001193125-26-318105:0
◆ Director · Executives · 23 Jul 2026
8,138 shares @ US$1.92 0.33% mcap 26.3% of flow Common Stock SEC:0001193125-26-318114:0
◆ Chief Executive Officer · Executives · 30 Jun 2026
3,880 shares Common Stock SEC:0001193125-26-295004:0
◆ Chief Executive Officer · Executives · 12 Jun 2026
7,761 shares Common Stock SEC:0001193125-26-274305:0
◆ Chief Executive Officer · Executives · 22 May 2026
3,700 shares @ US$2.37 0.12% mcap 100.0% of flow Common Stock SEC:0001193125-26-241999:0
◆ Director · Executives · 29 Apr 2026
6,515 shares @ US$2.59 0.33% mcap 1.8% of flow Common Stock SEC:0001193125-26-201557:0
◆ Director · Executives · 29 Apr 2026
6,032 shares @ US$2.59 0.30% mcap 100.0% of flow Common Stock SEC:0001193125-26-201474:0
◆ Director · Executives · 29 Apr 2026
6,274 shares @ US$2.59 0.31% mcap 2.6% of flow Common Stock SEC:0001193125-26-201489:0
◆ Director · Executives · 12 Jan 2026
5,406 shares @ US$2.89 35.1% of flow Common Stock SEC:0001193125-26-014117:0
◆ Director · Executives · 12 Jan 2026
5,622 shares @ US$2.89 2.3% of flow Common Stock SEC:0001193125-26-014116:0
◆ Director · Executives · 12 Jan 2026
5,839 shares @ US$2.89 1.7% of flow Common Stock SEC:0001193125-26-014115:0
◆ Director · Executives · 21 Nov 2025
5,340 shares @ US$3.16 1.8% of flow Common Stock SEC:0001193125-25-301033:0
◆ Director · Executives · 21 Nov 2025
5,142 shares @ US$3.16 2.3% of flow Common Stock SEC:0001193125-25-301026:0
◆ Director · Executives · 21 Nov 2025
4,183 shares @ US$3.16 46.2% of flow Common Stock SEC:0001193125-25-301025:0
◆ Vice President of Finance · Executives · 18 Aug 2025
10,775 shares 0Common Stock SEC:0000950170-25-110531:0
◆ Director · Executives · 3 Jul 2025
4,050 shares 0Common Stock SEC:0000950170-25-094387:0
◆ Director · Executives · 3 Jul 2025
3,400 shares 0Common Stock SEC:0000950170-25-094386:0
◆ Director · Executives · 13 Apr 2025
20,804 shares @ US$2.92 9.0% of flow Common Stock SEC:0000950170-25-090587:0
◆ Director · Executives · 13 Apr 2025
20,804 shares @ US$2.92 10.2% of flow Common Stock SEC:0000950170-25-054436:0
◆ Director · Executives · 13 Apr 2025
17,465 shares 0Common Stock SEC:0000950170-25-054429:0
▼ Director · Executives · 31 Dec 2024
2,182 shares @ US$2.01 0.5% of flow Common Stock SEC:0000950170-25-001257:0
▼ Chief Executive Officer · Executives · 1 Sept 2023
68,014 shares @ US$0.1403 16.3% of flow Common Stock SEC:0000950170-23-046504:0
25 of 37 declarations
Load more (12 remaining) 关于 Alaunos Therapeutics, Inc. Alaunos Therapeutics, Inc. 是一家生物制药公司，专注于开发癌症治疗的细胞疗法。它利用创新技术为患者创造个性化治疗方案。